December 20, 2024

Bio-interventional Cyclodialysis with Allograft Scleral Reinforcement for OAG

The combined procedure decreased IOP and improved BCVA.

Conexiant

December 20, 2024

Empagliflozin Reduces Risk of Diabetic Retinopathy Progression

Investigators found a 22% reduced risk of progression in patients with preexisting NPDR.

Conexiant

December 20, 2024

Workplace Discrimination in Ophthalmology

“Your husband also works, so you’re the second income.’”

Conexiant

December 17, 2024

Objective Perimetry More Sensitive than Standard Automated Perimetry

Study finds multifocal pupillographic objective perimetry is a faster, more reliable approach to glaucoma diagnostics compared to standard automated perimetry.

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

December 13, 2024

Faricimab Shows Better Anatomic Outcomes Compared to Aflibercept for nAMD

New data from TENAYA and LUCERNE supports “the vascular stabilizing effects of Ang-2 inhibition beyond anti-VEGF-A alone.”

Conexiant

December 13, 2024

Detailed Connections between Geographic Atrophy Lesions and Vision Loss

Study explores discord between BCVA and GA lesion size.

Conexiant

December 11, 2024

Polygenic Risk Scores Predict Glaucoma Risk Stratification

Even before a clinical manifestation of glaucoma, risk stratification can be achieved through intraocular pressure and vertical cup-disc ratio polygenic risk scores.

Conexiant

December 11, 2024

Benefits of Mono- and Multi-Treatments for Glaucoma

Findings from the Glaucoma Intensive Treatment Study (GITS).

Conexiant